VerImmune
Developer of vaccines for the treatment of cancer
📍 Baltimore, United States · Immunotherapy
Funding snapshot
Last roundSeed
Amount$470K
Date29 April 2025
About
Developer of vaccines for the treatment of cancer. The company is developing Anti-tumor Immune Redirection (AIR) a therapy that redirects the pre-existing immune memory from childhood vaccines or infections to fight cancer. They have developed a papillomavirus nanoparticle conjugated with viral antigens to treat cancer.
Latest news
No articles yet.
Similar startups
PayFlow
Embedded payments infrastructure for Southeast Asian marketplaces and platforms.
GreenGrid
Software for planning and operating distributed battery storage across Europe.
Immuneel
Developer of T-cell therapies for the treatment of cancer
ImmunoACT
Developer of cell and gene therapies for cancer treatment